SCHEMBL61606

SCHEMBL61606

COCN(CO)c1nc(N)nc(N)n1

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NPC1 O15118 2/20 0.31
SLC29A1 Q99808 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL337833 0.95 MAPT (0.32) MAPTLMNA
SCHEMBL10626876 0.94 MAPT (0.37) MAPTMEN1LMNAKMT2AL3MBTL1
SCHEMBL11407864 0.91 MAPT (0.37) MAPTMEN1LMNAKMT2AL3MBTL1
SCHEMBL8035956 0.88 MAPT (0.38) MAPTMEN1LMNAKMT2AL3MBTL1
SCHEMBL12379803 0.86 ALDH1A1 (0.33) SLC29A1
SCHEMBL11319118 0.84 ALDH1A1 (0.33)
SCHEMBL13140690 0.84 ALDH1A1 (0.32) SLC29A1
SCHEMBL11124582 0.84 MAPT (0.38) MAPTMEN1LMNAKMT2AL3MBTL1
SCHEMBL62017 0.84 ALDH1A1 (0.32) SLC29A1
SCHEMBL8029821 0.84 MAPT (0.42) MAPTMEN1LMNAKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2561552-B1 BACK SHEET FOR SOLAR CELL MODULE AND MANUFACTURING METHOD THEREOF KOLON INC (KR) 2018-01-24 EP claimed
US-20170131676-A1 METHOD FOR LUBRICATING IMAGING MEMBER XEROX CORPORATION 2017-05-11 US claimed
US-9575458-B2 Method for lubricating imaging member by applying lubricant-containing capsules via a non-contact applicator XEROX CORPORATION (US) 2017-02-21 US claimed
US-20150132037-A1 METHOD FOR LUBRICATING IMAGING MEMBER XEROX CORPORATION (US) 2015-05-14 US claimed
US-8951708-B2 Method of making toners XEROX CORPORATION (US) 2015-02-10 US claimed
US-20140363761-A1 METHOD OF MAKING TONERS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2014-12-11 US claimed
US-20140322522-A1 B-STAGEABLE SILICONE ADHESIVES ARTIFICIAL MUSCLE, INC. 2014-10-30 US claimed
EP-2766443-A1 B-STAGEABLE SILICONE ADHESIVES Bayer Intellectual Property GmbH (DE) 2014-08-20 EP claimed
US-20130130003-A1 BACK SHEET FOR SOLAR CELL MODULE AND MANUFACTURING METHOD THEREOF KOLON INDUSTRIES, INC. (KR) 2013-05-23 US claimed
WO-2013055733-A1 B-STAGEABLE SILICONE ADHESIVES BAYER MATERIALSCIENCE AG (DE) 2013-04-18 WO claimed
EP-2561552-A2 BACK SHEET FOR SOLAR CELL MODULE AND MANUFACTURING METHOD THEREOF Kolon Industries, Inc. (KR) 2013-02-27 EP claimed
WO-2011132976-A2 BACK SHEET FOR SOLAR CELL MODULE AND MANUFACTURING METHOD THEREOF KOLON INDUSTRIES, INC. (KR) 2011-10-27 WO claimed
WO-2001025360-A1 NOVEL RELEASE COATING KARAT DIGITAL PRESS L.P. (IL) 2001-04-12 WO claimed
US-5362833-A Multilayer element with substrates and coatings of crosslinked polysiloxanes EASTMAN KODAK COMPANY (US) 1994-11-08 US claimed
US-20260062604-A1 INFUSED AND COATED PROPPANT CONTAINING CHEMICAL TREATMENT AGENTS AND METHODS OF USING SAME CARBO CERAMICS INC. (US) 2026-03-05 US disclosed
US-20250382495-A1 BREATHABLE COATING COMPOSITIONS BROOKWOOD COMPANIES INCORPORATED (US) 2025-12-18 US disclosed
US-12410340-B1 Breathable coating compositions BROOKWOOD COMPANIES INCORPORATED (US) 2025-09-09 US disclosed
CN-1120558-A A rubber composition and a method for producing a vulcanized rubber SUMITOMO CHEMICAL CO (JP) 1996-04-17 CN disclosed
US-5420267-A Reaction of diketene and alkyl acetoacetate in solvent for coatings EASTMAN CHEMICAL COMPANY (US) 1995-05-30 US disclosed
US-5362833-A Multilayer element with substrates and coatings of crosslinked polysiloxanes EASTMAN KODAK COMPANY (US) 1994-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062604-A1 INFUSED AND COATED PROPPANT CONTAINING CHEMICAL TREATMENT AGENTS AND METHODS OF USING SAME FLNA, PLAT, SOST MAPT 195/4885MEN1 3975/4885LMNA 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.